8 drug(s) with this reaction
2,547 total reports
Drug Hypersensitivity has been reported as an adverse reaction across 8 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 2,547 adverse event reports mention drug hypersensitivity in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with drug hypersensitivity, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have drug hypersensitivity listed in their FDA adverse event reports, sorted by report count:
In addition to drug hypersensitivity, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
8 drug(s) manufactured by Chattem Inc have drug hypersensitivity listed in their FDA adverse event reports: TRIAMCINOLONE ACETONIDE, LIDOCAINE, MENTHOL, LIDOCAINE HCL, LEVOCETIRIZINE DIHYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, and others.
There are a combined 2,547 reports of drug hypersensitivity across 8 Chattem Inc drug(s) in the FDA adverse event database.